Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page displays the completed KEYNOTE-590 clinical trial record, including its study design, eligibility criteria, outcomes, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-11T02:18:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T01:10:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH-wide notice about changes to terminology appears above the page, and the site revision label advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:06:22.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T01:06:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and a minimal header, replacing the expected study-record content. A Home link is shown for navigation.
    Difference
    19%
    Check dated 2026-09-23T01:06:33.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, reflecting a new build of the page. This change represents a backend or frontend update rather than content changes for the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:29:53.000Z thumbnail image

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.